U-BX Technology Announces Direct Securities Offering
- Securities Purchase Agreement: U-BX Technology has entered into a securities purchase agreement with several investors to sell securities at a price of $0.30 per Unit, with expected gross proceeds of approximately $4.55 million, which will support the company's operational and capital needs.
- Unit Composition: Each Unit consists of one Class A ordinary share and a warrant to purchase 0.3 of a Class A ordinary share, a structure that not only attracts investor interest but also provides flexibility for future financing opportunities.
- Underwriter Arrangement: FT Global Capital, Inc. is acting as the exclusive placement agent, while Kingswood Capital Partners, LLC serves as co-placement agent, ensuring professionalism and market recognition for the offering, which is expected to close around April 29, 2026.
- Registration Statement Validity: The offering is conducted under an effective F-3 registration statement filed with the SEC on December 15, 2025, reflecting the company's commitment to compliance and transparency, which helps enhance investor confidence.
Trade with 70% Backtested Accuracy
Analyst Views on UBXG
About UBXG
About the author
U-BX Technology Announces Direct Securities Offering
- Securities Purchase Agreement: U-BX Technology has entered into a securities purchase agreement with several investors to sell securities at a price of $0.30 per Unit, with expected gross proceeds of approximately $4.55 million, which will support the company's operational and capital needs.
- Unit Composition: Each Unit consists of one Class A ordinary share and a warrant to purchase 0.3 of a Class A ordinary share, a structure that not only attracts investor interest but also provides flexibility for future financing opportunities.
- Underwriter Arrangement: FT Global Capital, Inc. is acting as the exclusive placement agent, while Kingswood Capital Partners, LLC serves as co-placement agent, ensuring professionalism and market recognition for the offering, which is expected to close around April 29, 2026.
- Registration Statement Validity: The offering is conducted under an effective F-3 registration statement filed with the SEC on December 15, 2025, reflecting the company's commitment to compliance and transparency, which helps enhance investor confidence.
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Edgewise Therapeutics Surge: Shares of Edgewise Therapeutics, Inc. rose 26.5% in pre-market trading after positive Phase 2 trial results for Sevasemten in Becker muscular dystrophy patients.
Market Movements: Several stocks saw significant pre-market gains, including Sidus Space (59.4%) and PureTech Health (22.8%), while Akoustis Technologies faced a sharp decline of 39.8% following a Chapter 11 filing.
U-BX Technology Ltd trading halted, news pending
Trading Halt: U-BX Technology (UBXG) Ltd has had its trading halted due to pending news, with updates expected soon.
Recent Developments: The company has recently announced a 1-for-16 reverse stock split and has been addressing compliance issues with Nasdaq.
U-BX Technology Ltd. Announced Receipt of Notification Letter from Nasdaq
U-BX Technology Ltd. Compliance Notification: U-BX Technology Ltd. received notifications from Nasdaq indicating that it has not met the minimum closing bid price and market value requirements for continued listing, but it has been granted a 180-day compliance period until April 21, 2025, to rectify these issues.
Company Overview and Services: U-BX is an insurance technology provider in China that offers AI-driven services such as digital promotion, risk assessment through its "Magic Mirror" algorithm, and bundled benefits for insurance carriers.
U-BX Technology receives noncompliance letter from Nasdaq
Nasdaq Notifications: U-BX Technology (UBXG) received notifications from Nasdaq indicating that its stock price has been below the $1.00 minimum requirement for 31 consecutive business days and its Market Value of Listed Securities has fallen below the $35M threshold for 30 consecutive business days.
Implications for Listing: These notifications highlight potential challenges for U-BX Technology in maintaining its listing on Nasdaq under the respective listing rules.
Nvidia's blockbuster earnings, CrowdStrike on the hot seat, and PCE inflation watch
Upcoming Earnings Reports: Notable companies set to report earnings next week include BHP Group, Nvidia, and Dell Technologies, with significant market movements expected for stocks like Workhorse Group and CrowdStrike following their reports.
Market Events and Trends: The week will feature elevated options trading volumes on various stocks, a merger vote for Marathon Oil Corporation, and the expiration of HSR review periods for acquisitions involving Boeing and Darden Restaurants.
U-BX Technology Announces Direct Securities Offering
- Securities Purchase Agreement: U-BX Technology has entered into a securities purchase agreement with several investors to sell securities at a price of $0.30 per Unit, with expected gross proceeds of approximately $4.55 million, which will support the company's operational and capital needs.
- Unit Composition: Each Unit consists of one Class A ordinary share and a warrant to purchase 0.3 of a Class A ordinary share, a structure that not only attracts investor interest but also provides flexibility for future financing opportunities.
- Underwriter Arrangement: FT Global Capital, Inc. is acting as the exclusive placement agent, while Kingswood Capital Partners, LLC serves as co-placement agent, ensuring professionalism and market recognition for the offering, which is expected to close around April 29, 2026.
- Registration Statement Validity: The offering is conducted under an effective F-3 registration statement filed with the SEC on December 15, 2025, reflecting the company's commitment to compliance and transparency, which helps enhance investor confidence.
Why Edgewise Therapeutics Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket
Edgewise Therapeutics Surge: Shares of Edgewise Therapeutics, Inc. rose 26.5% in pre-market trading after positive Phase 2 trial results for Sevasemten in Becker muscular dystrophy patients.
Market Movements: Several stocks saw significant pre-market gains, including Sidus Space (59.4%) and PureTech Health (22.8%), while Akoustis Technologies faced a sharp decline of 39.8% following a Chapter 11 filing.
U-BX Technology Ltd trading halted, news pending
Trading Halt: U-BX Technology (UBXG) Ltd has had its trading halted due to pending news, with updates expected soon.
Recent Developments: The company has recently announced a 1-for-16 reverse stock split and has been addressing compliance issues with Nasdaq.
U-BX Technology Ltd. Announced Receipt of Notification Letter from Nasdaq
U-BX Technology Ltd. Compliance Notification: U-BX Technology Ltd. received notifications from Nasdaq indicating that it has not met the minimum closing bid price and market value requirements for continued listing, but it has been granted a 180-day compliance period until April 21, 2025, to rectify these issues.
Company Overview and Services: U-BX is an insurance technology provider in China that offers AI-driven services such as digital promotion, risk assessment through its "Magic Mirror" algorithm, and bundled benefits for insurance carriers.
U-BX Technology receives noncompliance letter from Nasdaq
Nasdaq Notifications: U-BX Technology (UBXG) received notifications from Nasdaq indicating that its stock price has been below the $1.00 minimum requirement for 31 consecutive business days and its Market Value of Listed Securities has fallen below the $35M threshold for 30 consecutive business days.
Implications for Listing: These notifications highlight potential challenges for U-BX Technology in maintaining its listing on Nasdaq under the respective listing rules.
Nvidia's blockbuster earnings, CrowdStrike on the hot seat, and PCE inflation watch
Upcoming Earnings Reports: Notable companies set to report earnings next week include BHP Group, Nvidia, and Dell Technologies, with significant market movements expected for stocks like Workhorse Group and CrowdStrike following their reports.
Market Events and Trends: The week will feature elevated options trading volumes on various stocks, a merger vote for Marathon Oil Corporation, and the expiration of HSR review periods for acquisitions involving Boeing and Darden Restaurants.
